-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Max-1 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Max-1 in Solid Tumor Drug Details: Max-1 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Max-3 in Alopecia Areata
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Max-3 in Alopecia Areata Drug Details:Max-3 is under development for the treatment of alopecia areata and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Max-5 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Max-5 in Solid Tumor Drug Details: Max-5 is under development of the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Cisplatin + Vinblastine Sulphate) in Thyroid Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Cisplatin + Vinblastine Sulphate) in Thyroid Cancer Drug Details: Cisplatin in a fixed dose combination...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAX-4 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MAX-4 in Solid Tumor Drug Details:MAX-4 is under development for the treatment of myelodysplastic syndrome, acute...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAX-4 in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MAX-4 in Gastric Cancer Drug Details:MAX-4 is under development for the treatment of myelodysplastic syndrome, acute...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAX-4 in Adenocarcinoma Of The Gastroesophageal Junction
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MAX-4 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:MAX-4 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Zifanocycline in Community-Acquired Bacterial Pneumonia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Zifanocycline in Community-Acquired Bacterial PneumoniaDrug Details:Zifanocycline (KBP-7072) is under development for the treatment of acute bacterial...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAX-4 in Refractory Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MAX-4 in Refractory Acute Myeloid Leukemia Drug Details: MAX-4 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAX-4 in Metastatic Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MAX-4 in Metastatic Colorectal Cancer Drug Details: MAX-4 is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.